Status:

NOT_YET_RECRUITING

South Asians With Type 2 Diabetes at Risk for Depression

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will adapt a community health worker (CHW)-led Type 2 diabetes (T2D) intervention to include mental health and digital components using a trauma informed care approach, and test the feasibi...

Detailed Description

Specific Aim 1: Examine factors associated with distress, poor mental health, and comorbid T2D and depression among South Asians to inform pilot study structure and content. Specific Aim 2: Adapt CHW...

Eligibility Criteria

Inclusion

  • Aim 1 (Qualitative Component):
  • South Asian ethnicity based on self-report information
  • 18 years of age or older
  • Residing in NYC
  • Willingness and capacity to provide consent
  • Aim 3: Pilot Intervention:
  • South Asian ethnicity based on patient demographic information
  • 18 to 75 years of age
  • Appointment for routine non-emergent primary care in the past 12 months
  • Diagnosis of Type 2 diabetes
  • Patient Health Questionnaire-9 (PHQ-9) score of ≥5 (mild to severe depression)
  • Residing in NYC
  • Willingness and capacity to provide consent

Exclusion

  • Aim 1 (Qualitative Component):
  • • Diagnosed cognitive deficits or limited decision-making capacity
  • Aim 3: Pilot Intervention:
  • Pregnant at the time of screening
  • Type 1 diabetes or diabetes secondary to other conditions (e.g., steroid-induced, pancreatic insufficiency)
  • Malignancy or life-threatening illness with a life expectancy of \<5 years
  • Inability to perform unsupervised physical activity
  • Diagnosed cognitive deficits or limited decision-making capacity
  • Currently taking anti-depressant medication or receiving counseling services.

Key Trial Info

Start Date :

November 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07219667

Start Date

November 1 2025

End Date

December 1 2028

Last Update

October 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016